Health care spending in the US reached $4.9 trillion and increased 7.5 percent in 2023, growing from a rate of 4.6 percent in 2022. In 2023, the insured share of the population reached 92.5 percent, ...

In 2023, Transparency International worked as a united, global force for change. We have one vision: a world in which government, business, civil society and the daily lives of people are free of ...

Clockwise from top left: 'Insidious: The Red Door', 'Nun 2', 'Scream VI', 'Anyone But You' and 'Evil Dead Rise' Everett Collection Deadline’s Most Valuable Blockbuster tournament is back. While ...

OSHA has unveiled comprehensive workplace injury and illness statistics for 2023. This release marks the inaugural dataset under the newly established Improve Tracking of Workplace Injuries and ...

More than a million abortions were provided in the U.S. in 2023. That's a major finding from a report published Tuesday by the Guttmacher Institute, a research organization that supports access to ...

Join InSight Crime’s regional experts for an exclusive virtual panel examining 2025 homicide data across 31 countries, how organized crime shaped national trends, and what the widespread use of states ...

REUTER: The Texans' first two picks were the building blocks of their AFC South-winning squad, capturing Offensive and Defensive Rookie of the Year, respectively. Stroud played with the poise of a ...

This article was written by Jonathan Gardiner, Sustainable Indices Product Manager, and Tom Freke, Fixed Income Data Specialist at Bloomberg. Sustainable bond issuance topped more than a trillion ...

LONDON, Jan 11 (Reuters) - Global sales of fully electric and plug-in hybrid vehicles (PHEVs) rose 31% in 2023, down from 60% growth in 2022, according to market research firm Rho Motion. "The pace of ...

The U.S. labor market ended the year strong, creating more than 200,000 jobs in the last month of the year and nearly 2.7 million jobs in all of 2023, when seasonally adjusted. Consumer spending ...

Hot on the heels of the COVID-19 vaccine success story (including updated jabs that target Omicron subvariants of the rapidly shifting virus), 2023 saw the greenlighting of several new vital vaccines.

The FDA’s Center for Drug Evaluation and Research (CDER) approved 55 new drugs in 2023, as the small molecule and biologic pharmacopoeia continues to grow. This cohort is nearly 50% bigger than the ...